Search research articles
Contact Us
Filters
Showing results (171-180 of 187) with videos related to
Page
of 19
Sort By:
International Journal of Oncology
|
May 11, 2011
A phase-ii study testing weekly platinum derivative combination chemotherapy as 2nd-line treatment in patients with advanced small-cell lung-cancer
J Sculier, J Thiriaux, G Bureau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 9, 2011
Role of the multidisciplinary team in breast cancer management: results from a large international survey involving 39 countries
K S Saini, C Taylor, A-J Ramirez, et al.
British Journal of Cancer
|
May 3, 2007
Second-line paclitaxel in non-small cell lung cancer initially treated with cisplatin: a study by the European Lung Cancer Working Party
T Berghmans, J J Lafitte, J Lecomte, et al.
Antimicrobial Agents and Chemotherapy
|
May 1, 1996
Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto Infection Program
A Cometta, T Calandra, H Gaya, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 18, 2017
Clinical significance of CD73 in triple-negative breast cancer: multiplex analysis of a phase III clinical trial
L Buisseret, S Pommey, B Allard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 5, 2004
A phase III randomised study comparing two different dose-intensity regimens as induction chemotherapy followed by thoracic irradiation in patients with advanced locoregional non-small-cell lung cancer
J-P Sculier, J-J Lafitte, T Berghmans, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 4, 1999
A randomised phase III trial comparing consolidation treatment with further chemotherapy to chest irradiation in patients with initially unresectable locoregional non-small-cell lung cancer responding to induction chemotherapy. European Lung Cancer Working Party
J P Sculier, M Paesmans, J J Lafitte, et al.
ESMO Open
|
June 12, 2026
Long-term outcomes and treatment response in early-stage invasive lobular carcinoma: insights from a nationwide population-based study
G Nader-Marta, L Ameye, D Martins-Branco, et al.
The European Respiratory Journal
|
August 11, 2007
Chemotherapy improves low performance status lung cancer patients
J P Sculier, J J Lafitte, M Paesmans, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 5, 2001
HER-2 and topo-isomerase IIalpha as predictive markers in a population of node-positive breast cancer patients randomly treated with adjuvant CMF or epirubicin plus cyclophosphamide
A Di Leo, D Larsimont, D Gancberg, et al.
Page
of 19
Search research articles
Search
Showing results (171-180 of 187) with videos related to
Sort By:
Page
of 19
International Journal of Oncology
|
May 11, 2011
A phase-ii study testing weekly platinum derivative combination chemotherapy as 2nd-line treatment in patients with advanced small-cell lung-cancer
J Sculier, J Thiriaux, G Bureau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 9, 2011
Role of the multidisciplinary team in breast cancer management: results from a large international survey involving 39 countries
K S Saini, C Taylor, A-J Ramirez, et al.
British Journal of Cancer
|
May 3, 2007
Second-line paclitaxel in non-small cell lung cancer initially treated with cisplatin: a study by the European Lung Cancer Working Party
T Berghmans, J J Lafitte, J Lecomte, et al.
Antimicrobial Agents and Chemotherapy
|
May 1, 1996
Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto Infection Program
A Cometta, T Calandra, H Gaya, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 18, 2017
Clinical significance of CD73 in triple-negative breast cancer: multiplex analysis of a phase III clinical trial
L Buisseret, S Pommey, B Allard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 5, 2004
A phase III randomised study comparing two different dose-intensity regimens as induction chemotherapy followed by thoracic irradiation in patients with advanced locoregional non-small-cell lung cancer
J-P Sculier, J-J Lafitte, T Berghmans, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 4, 1999
A randomised phase III trial comparing consolidation treatment with further chemotherapy to chest irradiation in patients with initially unresectable locoregional non-small-cell lung cancer responding to induction chemotherapy. European Lung Cancer Working Party
J P Sculier, M Paesmans, J J Lafitte, et al.
ESMO Open
|
June 12, 2026
Long-term outcomes and treatment response in early-stage invasive lobular carcinoma: insights from a nationwide population-based study
G Nader-Marta, L Ameye, D Martins-Branco, et al.
The European Respiratory Journal
|
August 11, 2007
Chemotherapy improves low performance status lung cancer patients
J P Sculier, J J Lafitte, M Paesmans, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 5, 2001
HER-2 and topo-isomerase IIalpha as predictive markers in a population of node-positive breast cancer patients randomly treated with adjuvant CMF or epirubicin plus cyclophosphamide
A Di Leo, D Larsimont, D Gancberg, et al.
Page
of 19